A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.-Reference-Cited by-同舟云学术

A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.

Published:2022-08 Issue: Volume:236 Page:153983
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Marchese Paola Valeria,Mollica Veronica,De Biase Dario,Giunchi Francesca,Tassinari Elisa,Marchetti Andrea,Rosellini Matteo,Nuvola Giacomo,Maloberti Thais,Fiorentino Michelangelo,Massari Francesco

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference58 articles.

1. The end is nigh;Luft;J. Mol. Med. (Berl., Ger. ),2010

2. Telomere biology in healthy aging and disease;Oeseburg;Pflug. Arch.,2010

3. How telomeres solve the end-protection problem;de;Science,2009

4. The role of telomere biology in cancer;Xu;Annu. Rev. Pathol.,2013

5. Finding the end: recruitment of telomerase to telomeres;Nandakumar;Nat. Rev. Mol. Cell Biol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.;Pathology - Research and Practice;2024-01

2. TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance;Frontiers in Immunology;2023-01-12

3. Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers;Expert Review of Molecular Diagnostics;2022-11-02